(via TheNewswire)
Vancouver, British Columbia - TheNewswire - November 26, 2019 - CROP INFRASTRUCTURE CORP. (CNSX:CROP.CN) (OTC:CRXPF) (Frankfurt:2FR) (the "Company" or "CROP") announces that further to its press release dated November 7, 2019, its non-binding letter of intent (the "LOI") with MYM Nutraceuticals. ("MYM") has been terminated.
CROP continues to engage in discussions with MYM and now with additional parties regarding alternative transactions focused on specific assets of the Company.
For more information on the LOI and transactions contemplated thereunder, please see the Company's news release dated November 7, 2019.
About CROP Infrastructure Corp.
CROP is publicly listed on the CSE and trades under the symbol "CROP", in the US on the OTC under the symbol "CRXPF", and on the Frankfurt exchange under the symbol "2FR". CROP has developed a portfolio of asset investments including; two in Washington State, medical and recreational in California, a 1,012-acre Nevada Cannabis farm and a 500-acre Hemp CBD farm.
Company Contact
Michael Yorke
CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
Disclaimer for Forward-Looking Information
This press release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements in this news release include: (i) statements regarding the continued negotiations with MYM and additional third parties regarding alternative transactions focused on specific Company assets; and (ii) the Company's business plan going forward. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive shareholder or regulatory approvals; ability of the Company to give effect to its business plan; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The CSE (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this news release.
Copyright (c) 2019 TheNewswire - All rights reserved.